CONTACT: Steve Toll, Founder/Chief Executive Officer of Tampa Bay Recreation/ISM Saddles, 813-293-6974; and Dave Bunce, ISM Operations Commander, 512-968-1888
TAMPA, FLA -- Tampa Bay Recreation/ISM Saddles, maker of the world's most comfortable bicycle seat, is proud to announce that Triathlon icon Michellie Jones has joined the company to be the point-person in the company's relationships with professional athletes.
Jones, one of the world's premier and most decorated triathletes, has started this fall for ISM -- Ideal Seat Modification.
"Michellie is one of the most professional athletes the sport has ever known and we're pleased to have Michellie's expertise and knowledge as part of our ISM team," said Steve Toll, founder and chief executive officer of ISM Saddles.
Michellie will act as liaison between ISM and the professional athletes under contract with ISM. ISM has about 40 world-class athletes under contract such as U.S. Olympians Laura Bennett, Sarah Haskins and Andy Potts.
Michellie will also help ISM in its goal to sponsor a Pro Racing Tour Team.
Michellie, who is Australian, was the 2006 Ironman World Champion and has 160 career victories. Michellie was the seven-time Triathlete Magazine Triathlete of the Year.
“I am looking forward to taking on this new role at ISM and having the opportunity to share my expertise and knowledge I have required as a professional athlete over the last 23 years,” Michellie said.
ISM Saddles is internationally-known and recognized for producing one of the most comfortable bike saddles on the planet and for having its seat used by premier triathlon athletes, bike road racers, casual bicyclists and all age-groupers.
The ISM is a medically superior saddle to traditional bike seats because the pressure created by a traditional seat can lead to erectile problems, impotence and nerve damage from lack of blood flow.
“The word is out. You can be comfortable while riding a bike,” Steve Toll said.
Check out the ISM saddle at www.ismseat.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment